CC
DXCM icon

Centiva Capital’s DexCom DXCM Stock Holding History

Centiva Capital’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-7,900
Closed -$530K – 1857
2024
Q3 		$530K Sell
7,900
-2,100
-21% -$172K 0.01% 1219
2024
Q2 		$1.13M Buy
+10,000
New +$1.26M 0.02% 714
2023
Q3 		– Sell
-25,000
Closed -$3.21M – 1791
2023
Q2 		$3.21M Buy
+25,000
New +$3.02M 0.07% 267
2022
Q2 		– Sell
-800
Closed -$102K – 1760
2022
Q1 		$102K Hold
800
– – ﹤0.01% 1378
2021
Q4 		$107K Buy
+800
New +$115K ﹤0.01% 1049

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Centiva Capital's DXCM Position: Q3 2025 in Review

Centiva Capital sold out of DexCom (DXCM) in Q3 2025, closing a stake of 26,036 shares — an estimated $2.27M sold.

Centiva Capital first reported a position in DXCM in Q4 2021 and held it in 11 quarters. The position peaked at $2.27M in Q2 2025. 911 funds tracked by Wall St. Rank hold DXCM as of Q3 2025.

  • Centiva Capital reported no remaining DexCom position as of Q3 2025 after selling out during the quarter.
  • Centiva Capital sold 26,036 DexCom shares in Q3 2025, an estimated $2.27M.
  • Centiva Capital first reported a position in DexCom in Q4 2021 and held it in 11 quarters.
  • Centiva Capital's DexCom position peaked at $2.27M in Q2 2025.
  • 911 funds tracked by Wall St. Rank held DexCom as of Q3 2025.

Based on Centiva Capital's 13F filing for Q3 2025, filed 14 Nov 2025.